Arcutis Biotherapeutics (ARQT) Stock Insights

ARQT price $31.45 -0.23 -0.73%

Ticker
ARQT
Price
$31.45
Change
-0.23 -0.73%
Market cap ?
$3.95B
P/E ?
143.75
Forward P/E ?
65.52
Dividend yield ?
0.00%
Beta ?
1.58
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
54
Value
14
Quality
61
Growth
86

Stocklytics score rationale: value 14, quality 61, growth 86.

Financials

201720182019202020212022202320242025
00000368600059606000196542000376072000

Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151, a roflumilast cream administered topically, has successfully concluded late-stage clinical development for treating both plaque psoriasis and atopic dermatitis. Beyond its lead asset, Arcutis's pipeline includes…

Fair value

ARQT fair value $25.63. Price $31.45. Price is 23% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 130.88M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.6). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 125.69M. Net debt -36.64M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare ARQT

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—0.18—142.59M
2026-08-050.110.06129.86M118.85M
2026-05-06-0.09-0.02105.40M103.68M
2026-02-250.130.03129.50M113.06M
2025-10-280.06-0.1099.22M110.79M
2025-08-06-0.13-0.1881.50M80.63M
2025-05-06-0.20-0.2165.85M72.70M
2025-02-25-0.09-0.2871.36M60.52M
2024-11-06-0.33-0.4244.76M37.62M
2024-08-14-0.42-0.4830.86M29.08M
2024-05-14-0.32-0.6049.57M14.74M
2024-02-27-0.72-0.6513.53M11.34M
2023-11-03-0.73-0.9038.11M11.57M
2023-08-08-1.16-1.225.19M4.60M
2023-05-09-1.31-1.302.78M3.14M
2023-02-28-1.18-1.372.96M2.20M
2022-11-08-1.89-1.54725.00K614.29K
2022-08-04-1.31-1.38——
2022-05-05-1.27-1.42——
2022-02-22-1.42-1.41——
2021-11-04-1.14-1.09——
2021-08-05-0.84-0.91——
2021-05-04-0.76-0.96——
2021-02-16-0.79-0.89——
2020-11-05-1.01-0.95——
2020-08-11-0.94-0.84——
2020-05-12-1.15-0.92——
2020-03-19-6.18-9.21——
2020-01-31-0.40———
2019-06-30-0.22———
2019-03-31-0.17———
2018-12-31-0.15———
2018-09-30-0.21———
2018-06-30-0.08———
2018-03-31-0.08———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-23SCOTT ROBERT AOther0——
2026-10-23SCOTT ROBERT ABuy20.51K$31.20639.82K
2026-10-23SCOTT ROBERT ABuy8.66K$31.20270.29K
2026-10-23SCOTT ROBERT ABuy2.82K——
2026-10-15Welgus Howard G.Buy2.25K$8.6319.45K
2026-10-15Welgus Howard G.Buy1.02K$7.517.65K
2026-10-15Welgus Howard G.Buy822$6.525.36K
2026-10-15Welgus Howard G.Sell4.73K$26.93127.33K
2026-10-15Welgus Howard G.Sell2.25K$8.6319.45K
2026-10-15Welgus Howard G.Sell1.02K$7.517.65K
2026-10-15Welgus Howard G.Sell822$6.525.36K
2026-09-16Matsuda MasaruSell3.67K$25.0091.85K
2026-09-15Welgus Howard G.Buy2.25K$8.6319.46K
2026-09-15Welgus Howard G.Buy1.02K$7.517.65K
2026-09-15Welgus Howard G.Buy822$6.525.36K
2026-09-15Welgus Howard G.Sell4.73K$24.18114.37K
2026-09-15Welgus Howard G.Sell2.25K$8.6319.46K
2026-09-15Welgus Howard G.Sell1.02K$7.517.65K
2026-09-15Welgus Howard G.Sell822$6.525.36K
2026-09-08Matsuda MasaruSell9.99K$25.03249.99K
2026-08-27Curran TerrieBuy27.05K$8.63233.46K
2026-08-27Curran TerrieBuy11.15K$7.5183.72K
2026-08-27Curran TerrieSell27.05K$25.03677.10K
2026-08-27Curran TerrieSell11.15K$7.5183.72K
2026-08-27Curran TerrieSell27.05K$8.63233.46K
2026-08-20Curran TerrieBuy1.07K$7.518.05K
2026-08-20Curran TerrieSell1.07K$26.0427.91K
2026-08-20Curran TerrieSell1.07K$7.518.05K
2026-08-19Burnett PatrickSell1.70K$27.0045.82K
2026-08-17Welgus Howard G.Buy2.25K$8.6319.46K
2026-08-17Welgus Howard G.Buy1.02K$7.517.65K
2026-08-17Welgus Howard G.Buy822$6.525.36K
2026-08-17Welgus Howard G.Sell4.73K$26.18123.83K
2026-08-17Welgus Howard G.Sell2.25K$8.6319.46K
2026-08-17Welgus Howard G.Sell1.02K$7.517.65K
2026-08-17Welgus Howard G.Sell822$6.525.36K
2026-08-12Burnett PatrickSell6.70K$3.6424.39K
2026-08-12Burnett PatrickBuy6.70K$3.6424.39K
2026-08-12Burnett PatrickSell6.70K$26.08174.77K
2026-08-11Burnett PatrickSell8.30K$3.6430.21K
2026-08-11Burnett PatrickBuy8.30K$3.6430.21K
2026-08-11Burnett PatrickSell8.30K$26.52220.13K
2026-08-03Burnett PatrickSell955$26.1224.94K
2026-08-03Matsuda MasaruSell1.23K$26.1232.12K
2026-08-03Watanabe ToddSell4.38K$26.12114.26K
2026-07-15Peetz ChristopherBuy21.49K$27.78596.88K
2026-07-15Peetz ChristopherBuy13.01K$27.78361.42K
2026-07-15Peetz ChristopherBuy4.32K——
2026-07-15Peetz ChristopherOther0——
2026-07-15Welgus Howard G.Buy2.25K$8.6319.46K
2026-07-15Welgus Howard G.Buy1.02K$7.517.65K
2026-07-15Welgus Howard G.Buy822$6.525.36K
2026-07-15Welgus Howard G.Sell4.73K$26.91127.28K
2026-07-15Welgus Howard G.Sell2.25K$8.6319.46K
2026-07-15Welgus Howard G.Sell1.02K$7.517.65K
2026-07-15Welgus Howard G.Sell822$6.525.36K
2026-06-17Welgus Howard G.Sell635$25.6716.30K
2026-06-15LIN SUE-JEANSell4.95K$24.38120.59K
2026-06-15Welgus Howard G.Buy2.25K$8.6319.46K
2026-06-15Welgus Howard G.Buy1.02K$7.517.65K
2026-06-15Welgus Howard G.Buy822$6.525.36K
2026-06-15Welgus Howard G.Sell4.10K$24.4199.98K
2026-06-15Welgus Howard G.Sell2.25K$8.6319.46K
2026-06-15Welgus Howard G.Sell1.02K$7.517.65K
2026-06-15Welgus Howard G.Sell822$6.525.36K
2026-06-05Heron Patrick JOther0——
2026-06-05Heron Patrick JBuy5.78K——
2026-06-05Heron Patrick JBuy16.67K$21.23353.84K
2026-06-05LIN SUE-JEANBuy5.78K——
2026-06-05LIN SUE-JEANBuy16.67K$21.23353.84K
2026-06-05Welgus Howard G.Buy5.78K——
2026-06-05Welgus Howard G.Buy16.67K$21.23353.84K
2026-06-05Leonard Keith RBuy5.78K——
2026-06-05Leonard Keith RBuy16.67K$21.23353.84K
2026-06-05Curran TerrieBuy5.78K——
2026-06-05Curran TerrieBuy16.67K$21.23353.84K
2026-06-05Munshi AmitBuy16.67K$21.23353.84K
2026-06-05Munshi AmitBuy5.78K——
2026-06-05Gilbert Halley EBuy5.78K——
2026-06-05Gilbert Halley EBuy16.67K$21.23353.84K
2026-06-05Krishnamohan NehaBuy5.78K——
2026-06-05Krishnamohan NehaBuy16.67K$21.23353.84K
2026-05-11Vairavan LathaSell435$21.059.16K
2026-05-11Burnett PatrickSell222$21.054.67K
2026-05-04Matsuda MasaruSell7.37K$23.27171.54K
2026-05-04Matsuda MasaruSell884$23.6120.87K
2026-05-04Burnett PatrickSell684$23.6116.15K
2026-05-04Vairavan LathaSell1.34K$23.6131.66K
2026-05-04Watanabe ToddSell3.17K$23.6174.89K
2026-05-01Welgus Howard G.Sell7.14K$22.99164.22K
2026-04-01Welgus Howard G.Sell10.00K$23.88238.80K
2026-03-02Leonard Keith RBuy12.22K$7.5191.77K
2026-03-02Leonard Keith RBuy27.05K$8.63233.46K
2026-03-02Leonard Keith RSell39.27K$25.39997.19K
2026-03-02Leonard Keith RSell27.05K$8.63233.46K
2026-03-02Leonard Keith RSell12.22K$7.5191.77K
2026-03-02Welgus Howard G.Sell10.00K$25.65256.52K
2026-03-02Edwards Larry ToddSell3.58K$25.1690.18K
2026-03-02Edwards Larry ToddSell103$25.912.67K
2026-03-02Watanabe ToddSell36.28K$25.16912.85K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 282, holders +4 vs prior quarter. Ownership 101.51%.

HolderSharesChangeChange %Value
MONTANOVA CAPITAL, LLC12.44M110.00K+0.89%326.10M
BLACKROCK, INC.10.55M1.35M+14.62%276.50M
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.9.87M00.00%258.91M
RUBRIC CAPITAL MANAGEMENT LP8.27M00.00%216.88M
POLAR CAPITAL HOLDINGS PLC6.61M940.00K+16.59%173.23M
STATE STREET CORP5.82M-473.36K-7.52%152.67M
VANGUARD CAPITAL MANAGEMENT LLC4.99M117.22K+2.41%130.81M
MORGAN STANLEY4.45M232.08K+5.50%116.71M
JENNISON ASSOCIATES LLC4.22M-761.71K-15.29%110.62M
D. E. SHAW & CO., INC.3.95M1.45M+58.22%103.56M
UBS GROUP AG3.33M3.79K+0.11%87.39M
BANK OF AMERICA CORP /DE/2.99M766.14K+34.49%78.33M
GEODE CAPITAL MANAGEMENT, LLC2.98M-62.86K-2.06%78.21M
VANGUARD PORTFOLIO MANAGEMENT LLC2.43M474.32K+24.27%63.69M
ORBIMED ADVISORS LLC2.04M2.04MNew53.54M
FRANKLIN TEMPLETON INC1.93M-366.96K-15.97%50.63M
AMERICAN CENTURY COMPANIES INC1.93M461.80K+31.56%50.47M
GOLDMAN SACHS GROUP INC1.67M65.35K+4.08%43.74M
JUPITER TOPCO LLC1.41M1.41MNew36.99M
OBERWEIS ASSET MANAGEMENT INC/1.37M7.00K+0.51%36.00M
GILDER GAGNON HOWE & CO LLC1.31M-2.99M-69.49%34.43M
GW&K INVESTMENT MANAGEMENT, LLC1.29M299.63K+30.32%33.77M
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC1.27M-90.61K-6.68%33.18M
BAMCO INC /NY/1.25M180.93K+16.87%32.86M
CITADEL ADVISORS LLC1.16M1.16MNew30.42M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Arcutis Biotherapeutics (ARQT) Stock Insights

ARQT$31.45-0.23 -0.73%

$3.95B

Market Cap

143.75

P/E

65.52

Forward P/E

54

Score

Price History